Business
Why the Impedimed (ASX:IPD) share price will be on watch today
The Impedimed Limited (ASX: IPD) share price will be closely watched by investors this morning. This comes after the medical technology company announced that it has concluded its long-running Prevent trial.
At the closing bell yesterday, the Impedimed share price finished the day flat at 13 cents.
What did Impedimed announce?
It will be interesting to see which way the Impedimed share price moves today following the latest news.
According to the release, Impedimed advised that all Prevent trial patients have completed their follow-up visits. All 10 participating sites are now closed and the data gathered from the trial is currently being compiled. The company highlighted that study investigators have commenced their work on a…
-
Business14 hours agoBuy and hold NDQ and these ASX ETFs for 10 years
-
General16 hours ago“Accumulation of defects”. A-G report scathing on Navy shipbuilding
-
General16 hours agoG7 agrees to avoid higher taxes for US, UK companies
-
General20 hours agoAustralian racing driver James Wharton takes maiden Formula 3 race win